David E. Bloom
Affiliations: | Harvard T.H. Chan School of Public Health | Harvard University, Cambridge, MA, United States |
Google:
"David Bloom"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Stawasz A, Huang L, Kirby P, et al. (2020) Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits. Frontiers in Public Health. 8: 261 |
Remme M, Vassall A, Fernando G, et al. (2020) Investing in the health of girls and women: a best buy for sustainable development. Bmj (Clinical Research Ed.). 369: m1175 |
Nandi A, Kumar S, Shet A, et al. (2020) Childhood vaccinations and adult schooling attainment: Long-term evidence from India's Universal Immunization Programme. Social Science & Medicine (1982). 250: 112885 |
Sevilla JP, Stawasz A, Burnes D, et al. (2020) Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey. Human Vaccines & Immunotherapeutics. 1-14 |
Oskorouchi HR, Sousa-Poza A, Bloom DE. (2020) The Long-Term Cognitive and Schooling Effects of Childhood Vaccinations in China National Bureau of Economic Research |
Bloom DE, Kuhn M, Prettner K. (2020) The contribution of female health to economic development The Economic Journal. 130: 1650-1677 |
Christensen H, Al-Janabi H, Levy P, et al. (2019) Economic evaluation of meningococcal vaccines: considerations for the future. The European Journal of Health Economics : Hepac : Health Economics in Prevention and Care |
Bloom DE, Kirby PN, Pugh S, et al. (2019) COMMENTARY: WHY HAS UPTAKE OF PNEUMOCOCCAL VACCINES FOR CHILDREN BEEN SO SLOW? THE PERILS OF UNDERVALUATION. The Pediatric Infectious Disease Journal |
Rappuoli R, Black S, Bloom DE. (2019) Vaccines and global health: In search of a sustainable model for vaccine development and delivery. Science Translational Medicine. 11 |
Marten O, Koerber F, Bloom D, et al. (2019) A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease. Health and Quality of Life Outcomes. 17: 87 |